Search

Your search keyword '"Mycophenolate sodium"' showing total 18 results

Search Constraints

Start Over You searched for: Descriptor "Mycophenolate sodium" Remove constraint Descriptor: "Mycophenolate sodium" Database MEDLINE Remove constraint Database: MEDLINE
18 results on '"Mycophenolate sodium"'

Search Results

1. Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.

2. The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis.

3. Tolerability of mycophenolate sodium in renal transplant recipients.

4. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.

5. What Is the Teratogenic Risk of Mycophenolate?

6. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.

7. Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients.

8. Unusual Case of Acute Lung Injury in a Renal Allograft Recipient.

9. Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium.

10. Update on the Teratogenicity of Maternal Mycophenolate Mofetil.

11. Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation.

12. Gastrointestinal side effects in liver transplant recipients taking enteric-coated mycophenolate sodium vs. mycophenolate mofetil.

13. Everolimus with low-dose tacrolimus in simultaneous pancreas and kidney transplantation.

14. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.

15. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.

16. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.

17. A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial.

18. Treatment with everolimus is associated with a procoagulant state.

Catalog

Books, media, physical & digital resources